輸血診斷市場規模、佔有率和成長分析（按產品類型、檢測類型、最終用戶、技術和地區分類）—2025-2032年產業預測

全球輸血診斷市場預計在 2023 年達到 49 億美元，從 2024 年的 51.8 億美元成長到 2032 年的 80.7 億美元，在預測期（2025-2032 年）內複合年成長率為 5.7%。

全球輸血診斷市場正經歷顯著成長，這主要得益於安全輸血技術日益成長的需求以及篩檢技術的進步。外科手術、創傷病例和需要頻繁輸血的慢性疾病的增加，推動了對準確高效診斷解決方案的需求。衛生部門正積極致力於改善捐血篩檢流程和病原體檢測方法，進一步促進了市場擴張。技術創新正在革新輸血診斷，自動化免疫血液學檢查設備取代了手動儀器，最大限度地減少了人為誤差，並提高了實驗室效率。此外，核酸增幅檢查(NAT) 的引入也大大提升了血液安全。分子檢測方法、病原體減少系統、快速診斷試劑套件以及用於提高營運合規性和可追溯性的整合數位化管理解決方案的開發，也為市場帶來了積極影響。

全球輸血診斷市場促進因素

全球輸血診斷市場的主要促進因素之一是血液傳染疾病的日益增多以及對病人安全的日益重視。隨著醫療機構和監管機構將安全輸血實踐放在首位，對先進診斷技術的需求不斷成長，以確保血液製品的篩檢和檢測。對感染預防的日益重視，以及患者和臨床醫生對安全輸血流程重要性的意識提升，正在推動輸血診斷領域的創新和投資。因此，在技術進步和嚴格的安全通訊協定的支撐下，預計該市場將持續擴張。

限制全球輸血診斷市場的因素

全球輸血診斷市場的主要限制因素之一是先進診斷技術和設備的高成本。實施尖端檢測方案通常需要大量資金投入，這對於預算有限的小型醫院和診斷實驗室來說難以負擔。此外，複雜的監管要求和持續的操作人員培訓需求進一步推高了成本。這些經濟障礙可能會限制先進診斷方法的應用，最終阻礙市場成長潛力，並限制輸血領域採用更新、更有效率的技術。

全球輸血診斷市場趨勢

全球輸血診斷市場正呈現顯著的自動化和數位連接趨勢。實驗室正擴大採用全自動平台，以簡化檢體處理、檢測和結果解讀的工作流程。這種轉變不僅提高了檢測的一致性，而且對於滿足國家血庫和大型醫院等高通量環境的需求也至關重要。此外，實驗室資訊管理系統 (LIMS) 和雲端基礎資料分析等數位化工具的整合，有助於提高醫療網路間的可追溯性、即時監控和無縫資料共用。這種數位化轉型在加強監管合規性的同時，也提高了整個產業的營運效率。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管環境
• 管道分析

血液輸注診斷市場規模（按產品類型和複合年成長率分類）（2025-2032 年）

• 市場概覽
• 裝置
• 套件和試劑
• 軟體和服務

血液輸注診斷市場規模：檢測類型及複合年成長率（2025-2032）

• 市場概覽
• 傳染病篩檢（TTI）
• 血型鑑定/血型檢測
• 相容性和交叉測試
• 核酸增幅檢查（NAT）
• 其他輸血診斷

依最終用戶分類的輸血診斷市場規模及複合年成長率（2025-2032 年）

• 市場概覽
• 血庫和輸血服務
• 醫院/臨床實驗室
• 診斷實驗室
• 研究所

以技術及複合年成長率分類的輸血診斷市場規模（2025-2032 年）

• 市場概覽
• 血清學/免疫檢測
• 分子診斷（PCR/NAT）
• 次世代定序/先進平台
• 自動化高通量系統

血液輸注診斷市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2024 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2024 年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2022-2024年營收年比比較

主要企業簡介

• Grifols, SA
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd f
• Quotient Limited
• Abbott Laboratories
• Ortho Clinical Diagnostics
• BioMerieux SA
• Siemens Healthineers
• Immucor, Inc.
• Danaher Corporation
• BD（Becton, Dickinson & Company）
• DiaSorin SpA
• Thermo Fisher Scientific Inc.
• BAG Healthcare GmbH
• Merck KGaA
• Sysmex Corporation
• Danaher
• Beckman Coulter Inc.
• Novartis AG
• Fresenius Kabi AG
• Cepheid

結論與建議

Global Blood Transfusion Diagnostics Market size was valued at USD 4.9 billion in 2023 and is poised to grow from USD 5.18 billion in 2024 to USD 8.07 billion by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).

The global blood transfusion diagnostics market is witnessing considerable growth, driven by the increasing demand for safe transfusion practices and advancements in screening technologies. A rise in surgical procedures, trauma cases, and chronic diseases requiring frequent transfusions are fueling the need for accurate and efficient diagnostic solutions. Healthcare authorities are actively enhancing donor screening processes and pathogen detection methods, further propelling market expansion. Technological innovations have revolutionized blood transfusion diagnostics, with automated immunohematology analyzers replacing manual ones to minimize human error and boost lab efficiency. Moreover, the implementation of nucleic acid amplification testing (NAT) has significantly contributed to blood safety. The market is also benefiting from the development of molecular assays, pathogen-reduction systems, rapid diagnostic kits, and integrated digital management solutions for improved operational compliance and traceability.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Transfusion Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Transfusion Diagnostics Market Segments Analysis

Global Blood Transfusion Diagnostics Market is segmented by Product Type, Test Type, End-User, Technology and region. Based on Product Type, the market is segmented into Instruments, Kits & Reagents and Software & Services. Based on Test Type, the market is segmented into Infectious Disease Screening (TTIs), Blood Grouping & Typing, Compatibility & Cross-match Testing, Nucleic Acid Testing (NAT) and Other Transfusion Diagnostics. Based on End-User, the market is segmented into Blood Banks & Transfusion Services, Hospitals / Clinical Labs, Diagnostic Laboratories and Research Institutes. Based on Technology, the market is segmented into Serology / Immunoassay, Molecular Diagnostics (PCR/NAT), Next-Generation Sequencing / Advanced Platforms and Automation & High-Throughput Systems. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Transfusion Diagnostics Market

One of the key market drivers for the global blood transfusion diagnostics market is the increasing prevalence of bloodborne diseases and the rising emphasis on patient safety. As healthcare providers and regulatory bodies prioritize safe transfusion practices, there is a growing demand for advanced diagnostic technologies that ensure the screening and testing of blood products. This heightened focus on preventing infections, coupled with rising awareness among patients and clinicians about the importance of safe transfusion processes, drives innovation and investment in blood transfusion diagnostics. As a result, the market is expected to expand, bolstered by technological advancements and stringent safety protocols.

Restraints in the Global Blood Transfusion Diagnostics Market

One significant market restraint for the global blood transfusion diagnostics market is the high cost associated with advanced diagnostic technologies and equipment. The implementation of state-of-the-art testing solutions often requires substantial capital investment, which may not be feasible for smaller hospitals and diagnostic laboratories that operate under budget constraints. Additionally, the complexity of regulatory requirements and the need for continuous operator training further escalate expenses. These financial barriers can limit accessibility to advanced diagnostic methods, ultimately hindering the market's growth potential and restricting the adoption of newer, more efficient technologies in the blood transfusion sector.

Market Trends of the Global Blood Transfusion Diagnostics Market

The Global Blood Transfusion Diagnostics market is experiencing a significant trend towards increased automation and digital connectivity. Laboratories are increasingly adopting fully automated platforms that streamline workflows for sample handling, testing, and result interpretation. This shift not only enhances consistency but is crucial for meeting the demands of high-volume environments like national blood banks and large hospitals. Additionally, the integration of digital tools such as Laboratory Information Management Systems (LIMS) and cloud-based data analytics is facilitating improved traceability, real-time monitoring, and seamless data sharing throughout the healthcare network. This digital transformation bolsters regulatory compliance and drives overall operational efficiency within the sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape
• Pipeline Analysis

Global Blood Transfusion Diagnostics Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Instruments
• Kits & Reagents
• Software & Services

Global Blood Transfusion Diagnostics Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Infectious Disease Screening (TTIs)
• Blood Grouping & Typing
• Compatibility & Cross-match Testing
• Nucleic Acid Testing (NAT)
• Other Transfusion Diagnostics

Global Blood Transfusion Diagnostics Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Blood Banks & Transfusion Services
• Hospitals / Clinical Labs
• Diagnostic Laboratories
• Research Institutes

Global Blood Transfusion Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Serology / Immunoassay
• Molecular Diagnostics (PCR/NAT)
• Next-Generation Sequencing / Advanced Platforms
• Automation & High-Throughput Systems

Global Blood Transfusion Diagnostics Market Size & CAGR (2025-2032)

• North America (Product Type, Test Type, End-User, Technology)
  • US
  • Canada
• Europe (Product Type, Test Type, End-User, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Test Type, End-User, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Test Type, End-User, Technology)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Test Type, End-User, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Grifols, S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd f
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quotient Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson & Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BAG Healthcare GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations